<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to evaluate the association of expression level of α5β1-integrin and MMP-14 with clinicopathologic features and prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The expressions of α5β1-integrin and MMP-14 in <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue were detected with immunohistochemistry </plain></SENT>
<SENT sid="2" pm="."><plain>We estimated the five-year survival rate by the Kaplan-Meier method </plain></SENT>
<SENT sid="3" pm="."><plain>The positive expressions rates of α5β1-integrin and MMP-14 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue were 60.6% and 63.3% respectively, and there were significant differences on their positive expression rates between in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue and in <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa(P&lt;0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The expression rates of α5β1-integrin and MMP-14 in patients with poor histological differentiation, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and high clinical staging were heightened </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant difference (P&lt;0.05) on the five-year survival rate for α5β1-integrin expression, which was 44.6% in positive groups and 75.5% in negative groups </plain></SENT>
<SENT sid="6" pm="."><plain>And there was a significant difference (P&lt;0.05) on the five-year survival rate for MMP-14 expression, which was 48.2% in positive group and 73.1% in negative group </plain></SENT>
<SENT sid="7" pm="."><plain>The expression of α5β1-integrin and MMP-14 is correlated with the progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and α5β1-integrin and MMP-14 may be used as prognostic markers in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Keywords: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, immunohistochemistry, α5β1-integrin, MMP-14, prognosis, survival </plain></SENT>
</text></document>